DaVita 

$150.73
307
+$3.39+2.3% Friday 21:00

Statistics

Day High
151.51
Day Low
147.8
52W High
157.12
52W Low
101
Volume
879,122
Avg. Volume
1,103,648
Mkt Cap
10.07B
P/E Ratio
12.28
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
1.95
2.43
2.92
3.4
Expected EPS
2.336269
Actual EPS
N/A

Financials

7.31%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
25.63BRevenue
1.87BNet Income

Analyst Ratings

$155.25Average Price Target
The highest estimate is 190.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
25%
Hold
50%
Sell
25%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DVA. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Show more...
CEO
Mr. Javier J. Rodriguez
Employees
76000
Country
US
ISIN
US23918K1088

Listings

0 Comments

Share your thoughts

FAQ

What is DaVita stock price today?
The current price of DVA is $150.73 USD — it has increased by +2.3% in the past 24 hours. Watch DaVita stock price performance more closely on the chart.
What is DaVita stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange DaVita stocks are traded under the ticker DVA.
Is DaVita stock price growing?
DVA stock has risen by +1.2% compared to the previous week, the month change is a +38.07% rise, over the last year DaVita has showed a +5.85% increase.
What is DaVita market cap?
Today DaVita has the market capitalization of 10.07B
When is the next DaVita earnings date?
DaVita is going to release the next earnings report on April 30, 2026.
What were DaVita earnings last quarter?
DVA earnings for the last quarter are 3.4 USD per share, whereas the estimation was 3.24 USD resulting in a +4.88% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is DaVita revenue for the last year?
DaVita revenue for the last year amounts to 25.63B USD.
What is DaVita net income for the last year?
DVA net income for the last year is 1.87B USD.
How many employees does DaVita have?
As of February 22, 2026, the company has 76,000 employees.
In which sector is DaVita located?
DaVita operates in the Health Care sector.
When did DaVita complete a stock split?
The last stock split for DaVita was on September 09, 2013 with a ratio of 2:1.
Where is DaVita headquartered?
DaVita is headquartered in Denver, US.